In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series B lands $5.2mm for Hemovent

Executive Summary

Hemovent GMBH raised $5.2mm in its Series B financing from undisclosed institutional and strategic investors. The company has developed the Mobybox self-contained, fully integrated extracorporeal membrane oxygenation /extracorporeal life support system that can support or replace heart and lung function in the event of cardiac and/or respiratory failure. Funding from the round will help Hemovent gain FDA approval for the device, expected later this year.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies